| 000 | 01922 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517140221.0 | ||
| 264 | 0 | _c20180319 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a2241-5955 | ||
| 024 | 7 |
_a10.1016/j.hjc.2017.01.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarketou, Maria | |
| 245 | 0 | 0 |
_aLong-term serial changes in platelet activation indices following sirolimus elution and bare metal stent implantation in patients with stable coronary artery disease. _h[electronic resource] |
| 260 |
_bHellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese _c |
||
| 300 |
_a43-48 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCoronary Artery Disease |
| 650 | 0 | 4 |
_aCoronary Restenosis _xetiology |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Activation _xphysiology |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aStents _xadverse effects |
| 650 | 0 | 4 |
_aThrombosis _xpathology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKochiadakis, George E | |
| 700 | 1 | _aGiaouzaki, Aikaterini | |
| 700 | 1 | _aSfiridaki, Katerini | |
| 700 | 1 | _aPetousis, Stelios | |
| 700 | 1 | _aMaragoudakis, Fragiskos | |
| 700 | 1 | _aRoufas, Konstantinos | |
| 700 | 1 | _aVougia, Despoina | |
| 700 | 1 | _aLogakis, John | |
| 700 | 1 | _aChlouverakis, Gregory | |
| 700 | 1 | _aVardas, Panos E | |
| 773 | 0 |
_tHellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese _gvol. 58 _gno. 1 _gp. 43-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.hjc.2017.01.009 _zAvailable from publisher's website |
| 999 |
_c26869060 _d26869060 |
||